Iterative Health
Nagu Chidambaram is an experienced investment professional currently working at Insight Partners as part of the investment team since May 2019, with a focus on companies such as Slice, M2P, Digital Owl, Iterative Scopes, Viz.ai, and Flip. Nagu serves as a board observer for several firms, including M2P Fintech, Privado.ai, inDriver, and Iterative Health. Prior to this, Nagu held the position of investor at JMI Equity from 2018 to 2019 and worked as a business analyst at ThreeWire, Inc. from 2017 to 2018. Nagu holds a Bachelor's degree in Finance and Financial Management Services from The Wharton School.
This person is not in any teams
This person is not in any offices
Iterative Health
1 followers
Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD). We use advanced machine learning and computer vision to interpret endoscopic images along with other types of data, helping clinicians to better assess patients with potential GI problems. This gives practitioners enhanced capabilities in the detection, annotation, disease scoring and treatment of GI related diseases. Iterative Health is initially applying these advances towards standardizing disease severity characterization for inflammatory bowel disease. Ultimately, the company aims to establish more meaningful endpoints to serve as better predictors of both therapeutic response and disease outcomes. The company is headquartered in Cambridge, Massachusetts.
Employees
51-200